Advertisement
Screener

Intellicell Biosciences, Inc. Form D

Intellicell Biosciences, Inc. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2012-12-03: Federal exemption Rule 506; Types of securities offered Units of common stock and common stock purchase warrants; Date of first sale 2012-10-01; Total offering amount $6,000,000.
  • 2012-11-13: Federal exemption Rule 506; Types of securities offered Series E Convertible Preferred Stock; Date of first sale 2012-10-01; Total offering amount $6,000,000.
  • 2012-10-16: Federal exemption Rule 506; Types of securities offered Series E Convertible Preferred Stock; Date of first sale 2012-10-01; Total offering amount $6,000,000.
  • 2012-03-26: Federal exemption Rule 506; Types of securities offered Common Stock and Warrants to Purchase Shares of Common Stock; Date of first sale 2012-02-09; Total offering amount $3,500,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2012-12-03
D/A
Rule 506Units of common stock and common stock purchase warrants2012-10-01$6,000,000$375,000$5,625,0003
2012-11-13
D/A
Rule 506Series E Convertible Preferred Stock2012-10-01$6,000,000$125,000$5,875,0002
2012-10-16Rule 506Series E Convertible Preferred Stock2012-10-01$6,000,000$25,000$5,975,0001
2012-03-26
D/A
Rule 506Common Stock and Warrants to Purchase Shares of Common Stock2012-02-09$3,500,000$2,475,000$1,025,00018
2012-02-23Rule 506Common Stock and Warrants to purchase shares of Common Stock2012-02-09$3,500,000$2,040,000$1,460,00013
2011-11-07Rule 506Equity; OptionToAcquire2011-10-11$10,000,000$340,000$9,660,0003